Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (12)

2024

  1. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology, Vol. 17

  2. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

    Alimentary Pharmacology and Therapeutics

2023

  1. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91

  2. Exploring the Chemistry of Ocimum Species under Specific Extractions and Chromatographic Methods: A Systematic Review

    ACS Omega, Vol. 8, Núm. 12, pp. 10747-10756

  3. Influence of altitude on the physicochemical composition and antioxidant capacity of strawberry: a preliminary systematic review and meta-analysis

    Phytochemistry Reviews, Vol. 22, Núm. 6, pp. 1567-1584

  4. Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic Review

    Journal of Clinical Medicine, Vol. 12, Núm. 23

2022

  1. Influence of Altitudes and Development Stages on the Chemical Composition, Antioxidant, and Antimicrobial Capacity of the Wild Andean Blueberry (Vaccinium floribundum Kunth)

    Molecules, Vol. 27, Núm. 21

2019

  1. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study

    Journal of Crohn's & colitis, Vol. 13, Núm. 12, pp. 1492-1500

  2. Effects of quercetin metabolites on triglyceride metabolism of 3T3-L1 preadipocytes and mature adipocytes

    International Journal of Molecular Sciences, Vol. 20, Núm. 2

  3. In vitro approach for evaluation of carob by-products as source bioactive ingredients with potential to attenuate metabolic syndrome (MetS)

    Heliyon, Vol. 5, Núm. 1

2005

  1. Time-dependent pharmacokinetics of cyclosporine (Neoral®) in de novo renal transplant patients

    Journal of Clinical Pharmacy and Therapeutics, Vol. 30, Núm. 6, pp. 549-557

2004

  1. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients

    Acta Anaesthesiologica Scandinavica, Vol. 48, Núm. 8, pp. 1038-1048